Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Institute for Biomedical Research of Barcelona (IIBB), National Spanish Research Council (CSIC), 08036 Barcelona, Spain.
Int J Mol Sci. 2022 Jun 20;23(12):6840. doi: 10.3390/ijms23126840.
Ischaemic stroke is a complex disease with some degree of heritability. This means that heritability factors, such as genetics, could be risk factors for ischaemic stroke. The era of genome-wide studies has revealed some of these heritable risk factors, although the data generated by these studies may also be useful in other disciplines. Analysis of these data can be used to understand the biological mechanisms associated with stroke risk and stroke outcome, to determine the causality between stroke and other diseases without the need for expensive clinical trials, or to find potential drug targets with higher success rates than other strategies. In this review we will discuss several of the most relevant studies regarding the genetics of ischaemic stroke and the potential use of the data generated.
缺血性中风是一种具有一定遗传性的复杂疾病。这意味着遗传因素,如基因,可能是缺血性中风的危险因素。全基因组研究时代揭示了一些这些可遗传的危险因素,尽管这些研究产生的数据在其他学科中也可能有用。对这些数据的分析可用于了解与中风风险和中风结果相关的生物学机制,在无需昂贵的临床试验的情况下确定中风与其他疾病之间的因果关系,或者找到比其他策略成功率更高的潜在药物靶点。在这篇综述中,我们将讨论几个关于缺血性中风遗传学和潜在数据应用的最相关的研究。